health - "medicine"

Many people in Medicare with diabetes, high blood pressure and other chronic conditions stop taking their medicine when faced ...

The Substance Abuse and Mental health Services Administration (SAMHSA) today announced a three-year cooperative agreement grant award totaling $1.5 million to the American Society of Addiction medicine to train physicians and other health professionals on the appropriate use of methadone in the treatment of pain and opioid addiction.read more

Vaccinating young teens to prevent cervical cancer might be cost-effective, but a new study questions the cost-effectiveness of vaccinating older teenagers and women in their 20s, the Wall Street Journal reports. The study, conducted by researchers at the Harvard School of Public health, was published Thursday in the New England Journal of medicine.

The cost of administering human papillomavirus vaccines is justified in pre-adolescent girls but becomes less so as the age of women receiving the injection increases, according to a study published Thursday in the New England Journal of medicine, the Wall Street Journal reports.

NovaRx Corporation announced that the company initiated its pivotal Phase III clinical trial of Lucanix(R) (belagenpumatucel-L) in the treatment of advanced non-small cell lung cancer (NSCLC). The first patient enrolled in the study was treated by Dr. Lyudmila Bazhenova the trial's principal investigator at the University of California, San Diego School of medicine.

Ardea Biosciences, Inc. (Nasdaq: RDEA) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom has authorized a Phase 1 study evaluating RDEA594 in normal healthy volunteers. RDEA594 is the Company's lead product candidate for the treatment of gout.

(University of Alabama at Birmingham) Magazine's special cancer edition focuses on a pair of University of Alabama at Birmingham doctors because of their research into a field call viral gene therapy, or virotherapy. The two were optimistic of the promise; 'We envision a substantial role for viruses -- that is, therapeutic viruses -- in 21st-century medicine,' they said.

(Society of Nuclear Medicine) SNM and the American Society for Therapeutic Radiation and Oncology will cosponsor a symposium this fall examining the impact of translational advances on radiation oncology and cancer imaging. The two-day meeting, which takes place Oct. 17-18, will bring together some of the world's leading experts and young investigators in the emerging field of molecular imaging.

(University of Kentucky) A new book by Dr. James W. Anderson gives an overview of glycemic health and highlights the use of novel and upcoming nutraceutical ingredients. LEXINGTON, Ky. (August 20, 2008) - People at high risk for developing type 2 diabetes might be able to delay or prevent the disease by taking certain food supplements and making lifestyle changes, according to a new book by Dr. James W. Anderson, an internationally recognized authority on metabolic diseases and weight loss and professor emeritus of medicine and clinical nutrition at the University of Kentucky College of medicine. Diabetes is a worldwide epidemic, and it is growing at an alarming rate. In 2006, the United Nations declared it an international health threat comparable to HIV/AIDS. However, emerging evidence suggests that risk of diabetes can be reduced by a combination of weight loss, exercise, dietary changes and the use of supplements called 'nutraceuticals,' extracts of certain foods purported to hav